Results 201 to 210 of about 1,659,457 (221)
Some of the next articles are maybe not open access.

Epicardial fat and atrial fibrillation: the perils of atrial failure.

Europace, 2022
Obesity is a heterogeneous condition, characterized by different phenotypes and for which the classical assessment with body mass index may underestimate the real impact on cardiovascular (CV) disease burden.
Andrea Poggi   +5 more
semanticscholar   +1 more source

Epicardial fat and incident heart failure with preserved ejection fraction in patients with coronary artery disease.

International Journal of Cardiology, 2022
BACKGROUND We aimed to determine, whether epicardial adipose tissue (EAT) as local source of inflammation, as well as its change over time, associates with the development of heart failure with preserved ejection fraction (HFpEF) in patients with ...
A. Mahabadi   +7 more
semanticscholar   +1 more source

Effect of obesity and epicardial fat/fatty infiltration on electrical and structural remodeling associated with atrial fibrillation in a novel canine model of obesity and atrial fibrillation: A comparative study

Cardiovascular Electrophysiology, 2021
How obesity and epicardial fat influence atrial fibrillation (AF) is unknown.
N. Otsuka   +13 more
semanticscholar   +1 more source

Epicardial fat in heart failure—Friend, foe, or bystander

Obesity Reviews
Epicardial adipose tissue (EAT) is a fat depot covering the heart. No physical barrier separates EAT from the myocardium, so EAT can easily affect the underlying cardiac muscle. EAT can participate in the development and progression of heart failure with
A. Paterek   +6 more
semanticscholar   +1 more source

Association of Epicardial Fat Volume With the Extent of Coronary Atherosclerosis and Cardiovascular Adverse Events in Asymptomatic Patients With Diabetes

Angiology, 2021
Epicardial adipose tissue has a paracrine effect, enhancing coronary artery atherosclerotic plaque development. This study evaluated epicardial fat volume (EFV), adipokines, coronary atherosclerosis, and adverse cardiovascular events in a cohort of ...
S. Venuraju   +5 more
semanticscholar   +1 more source

Effects of Dapagliflozin on Epicardial Fat Thickness in Patients with Type 2 Diabetes and Obesity

Obesity, 2020
Epicardial adipose tissue (EAT) thickness is a marker of visceral fat and an emerging therapeutic target. Dapagliflozin, a selective sodium‐glucose cotransporter 2 inhibitor, improves glucose control and induces moderate weight loss in patients with type
G. Iacobellis, Silvia Gra-Menendez
semanticscholar   +1 more source

Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: Three-year follow-up of a randomized study.

Heart Rhythm, 2019
BACKGROUND Botulinum toxin (BTX) injections into epicardial fat pads in patients undergoing coronary artery bypass grafting (CABG) has resulted in suppression of atrial fibrillation (AF) during the early postoperative period through 1-year of follow-up ...
A. Romanov   +13 more
semanticscholar   +1 more source

Epicardial fat and the risk of atrial tachy-arrhythmia recurrence post pulmonary vein isolation: a computed tomography study

The International Journal of Cardiovascular Imaging, 2021
G. Goldenberg   +11 more
semanticscholar   +1 more source

Effect of Epicardial Fat on Electroanatomical Mapping and Epicardial Catheter Ablation

Journal of the American College of Cardiology, 2010
Frank Bogun   +2 more
exaly  

Association of Epicardial Fat With Cardiovascular Risk Factors and Incident Myocardial Infarction in the General Population: The Heinz Nixdorf Recall Study.

Journal of the American College of Cardiology, 2013
Amir Abbas Mahabadi   +2 more
exaly  

Home - About - Disclaimer - Privacy